Bio-Techne

Asuragen is a fully integrated diagnostics company focused on molecular oncology and early detection of cancer, with an emphasis on microRNA. Asuragen's current diagnostics product portfolio consists of Signature® Genetic and Oncology Testing products, as well as industry leading controls and standards engineered using its patented Armored RNA® technology. In addition to its diagnostics products, Asuragen offers GLP testing services and an established cGMP manufacturing facility that allow it to span the spectrum of discovery, testing, production and commercialization.

Eminence developing and manufacturing CHO chemically-defined media, and providing cell line and media formulation development services. Eminence has developed EmCD CHO® basal medium and EmCD CHO® Feed for CHO-K1, CHO-S, CHO-DG44 and other cell lines. Eminence offers a wide range of tailor-made services including medium formulation development/optimization and media production to cater to individual customers' diverse needs. With an experienced R&D and production team, Eminence owns GMP-compliant medium production plants and state-of-the-art labs to provide best-of the-breed products and flexible services for customers, while helping biopharma companies comply with the increasingly stringent requirements for safety and effectiveness in the biopharma industry.

B-MoGen Biotechnologies Inc is a genome engineering startup located in Minneapolis, Minnesota. Founded in 2015, B-MoGen has entered strategic partnerships with biotechnology companies, completed projects for clients in academia and industry, and successfully licensed and developed novel intellectual property focused on genome engineering. B-MoGen Biotechnologies Inc offers custom tools for gene delivery and gene editing.

Exosome Diagnostics is developing biofluid-based molecular diagnostic tests for use in personalized medicine. Exosomes and other microvesicles are shed into all biofluids, including blood, urine and cerebrospinal fluid, forming a highly enriched source of intact, disease-specific nucleic acids. The Company's proprietary exosome technology makes use of this natural enrichment to achieve high sensitivity and specificity for rare gene transcripts and the expression of genes responsible for cancers and other diseases.

Quad Technologies is disrupting cell separation and cell therapy workflows by providing researchers with a simple, cell-friendly capture and release technology for cell isolation. Their new MagCloudz™ Streptavidin Cell Separation kit, featuring novel QuickGel™ technology platform, enables straightforward, scalable and fast cell separation with unique magnetic particle dissociation, resulting in complete label free cells. For applications such as T Cell purification, stem cell isolation, circulating tumor cell (CTC) separation and immunotherapy, this unique solution offers drastically improved cell viability, purity and recovery while maintaining a native cellular phenotype.

Astute Medical is dedicated to improving the diagnosis of high-risk medical conditions and diseases through the identification and validation of protein biomarkers that can serve as the basis for novel diagnostic tests. The Company's focus is on community and hospital-acquired acute conditions that require rapid diagnosis and risk assessment. The company's current areas of interest include abdominal pain, acute coronary syndromes, cerebrovascular injury, kidney injury and sepsis. Founded in 2007, the company is led by Christopher Hibberd and Paul McPherson, former members of the management at Biosite Incorporated, a leading diagnostics company acquired by Inverness Medical Innovations in 2007 for $1.7 billion. Hibberd served at Biosite for 10 years, most recently as Senior Vice President Corporate Development. Dr. McPherson was at Biosite for 14 years, most recently as Vice President Research and Development.

Advanced Cell Diagnostics (ACD) is a leader in the emerging field of molecular pathology, developing cell- and tissue-based diagnostic tests for personalized medicine. Based in the heart of Silicon Valley, ACD was founded and managed by experienced entrepreneurs in the life science industry.

Space Import Export S.r.l. is a distribution company that has been working in the Life Science business since 1985, specialized in the fields of Biomedical Research and Diagnostic Market. Our distribution activity has grown, through an active cooperation with a sister company, called LaboSpace, provider of laboratory services, with branches in Italy, UK and USA.

Zephyrus Biosciences provides research tools to enable protein analysis at the single-cell level. Addressing the burgeoning single-cell analysis market, our first product, the scWestern system, enables western blotting on individual cells for the first time. Researchers will utilize Zephyrus’s products to gain new insights into the biology of cancer, stem cells, neurology, and human disease and development. It was founded in 2013 and headquartered in Berkeley, California.

CLINIQA Corp is specializes in the manufacturing and commercialization of quality controls and calibrators. For over 40 years, CLINIQA has earned an enviable track record within the IVD industry by manufacturing and marketing high quality products, designed to improve the accuracy of diagnostic tests. CLINIQA operates from facilities in San Diego County in Southern California. CLINIQA's Quality Management Systems are compliant with the FDA QSR and certified to EN ISO 13485:2012 and ISO 13485:2003 standards. CLINIQA specializes in the supply of reagents, controls, calibrators, calibration verifiers, proficiency test materials, biologicals and contract manufacturing services. Liquid QC® products from CLINIQA feature the benefits of "ready-to-use" convenience, 30-day open vial stability, and a 24-36 month shelf life when refrigerated. With total dedication to quality and a unique focus on liquid stablization techology, CLINIQA's products consistently meet market demands for stability, convenience, and reproducibility.

CyVek, Inc. engages in the development of a platform technology for measuring analytes in biological samples. The company was incorporated in 2008 and is based in Wallingford, Connecticut.

The mission of Novus Biologicals, LLC is to accelerate scientific discovery by developing and marketing unique products for the lifesciences. Novus Biologicals is also organized to provide the biological research community with a mechanism for commercializing unique biological materials. We also focus on continually monitoring scientific trends and supply materials to serve these trends. By making these products widely available to institutional and commercial researchers, Novus Biologicals plays an important role in furthering biological research. All of Novus Biologicals products are supplied with detailed technical information and ongoing support. By serving both niche and emerging markets, Novus Biologicals has built solid partnerships with our customers.

Alpha Innotech Corp. manufactures and sells analytical laboratory instruments, software, and consumables used in life science research laboratories for the study of nucleic acids, proteins, and cells worldwide. Products The company's imaging systems, sold under its trademarks AlphaDigiDoc, AlphaImager, FluorChem and red, comprise a digital camera and bench-top dark enclosure and are used to detect, archive, and analyze fluorescent, chemiluminescent and visible signals from biological samples, such as DNA, proteins and bacterial colonies. Alpha Innotech Corp. was founded in 1992.

Shanghai PrimeGene Bio-Tech Co is a leader in the China market in the development, manufacture and distribution of recombinant proteins for research and diagnostic applications.

CyVek, Inc. engages in the development of a platform technology for measuring analytes in biological samples. The company was incorporated in 2008 and is based in Wallingford, Connecticut.

Bionostics is a world-leading developer and manufacturer of high quality, turnkey calibrators and quality control products for original equipment manufacturers (OEMs) for critical care / point-of-care and diabetes diagnostics test systems. Located in Devens, Massachusetts, Bionostics offers a variety of services to provide high quality, cost effective, turn-key solutions to our customers, large and small. We maintain professional associations with customers and suppliers, striving to work together in relationships that are beneficial for all parties. As a key partner to world-class OEMs, we are acutely aware of our responsibility to maintain and foster the brand identities of our clients. Our quality systems are certified to ISO 9001:2008 and 13485:2003. Our products are listed as Class I and Class II with the US FDA, bear Class II and Class III Medical Device Licenses in Canada and fully comply with requirements of 98/79/EC, the In-Vitro Diagnostics Directive.

Tocris Holdings is a supplier of reagents for non-clinical life science research.

ChemoCentryxis a biopharmaceutical company developing new medications targeted at inflammatory and autoimmune diseases and cancer. ChemoCentryx focuses on the discovery, development, and commercialization of orally-administered small molecule therapeutics that target chemokine receptors and related chemo-attractant receptors. The company's small molecule product candidates are designed to target a specific chemokine or chemo-attractant receptor, thereby blocking the inappropriate immune system cascade underlying a given disease.